Status:

UNKNOWN

Effect of BNP (Brain Natriuretic Peptides) on Endothelial Dysfunction Induced by Coronary Angioplasty

Lead Sponsor:

The Baruch Padeh Medical Center, Poriya

Conditions:

Coronary Artery Disease

Eligibility:

All Genders

Phase:

PHASE4

Brief Summary

Patients receiving BNP or nitroglycerin (IV) during the angioplasty procedure. 24 h after the procedure, vascular reactivity will be re-examined using the brachial artery flow-mediated dilatation stud...

Eligibility Criteria

Inclusion

  • coronary artery disease -

Exclusion

  • CHF and/or reduced LV function, or renal failure with Creatinine \>2mg%
  • \-

Key Trial Info

Start Date :

July 1 2005

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 1 2013

Estimated Enrollment :

500 Patients enrolled

Trial Details

Trial ID

NCT00262574

Start Date

July 1 2005

End Date

June 1 2013

Last Update

August 9 2011

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The Baruch Pade medical center, Poriya

Tiberias, Israel, 15208

Effect of BNP (Brain Natriuretic Peptides) on Endothelial Dysfunction Induced by Coronary Angioplasty | DecenTrialz